Chromosome imbalances and alterations of AURKA and MYCN genes in children with neuroblastoma

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 11, 2012, Pages 5391-5397

  Inandiklioǧlu, Nihal ^a   Yilmaz, Sema ^a   Demirhan, Osman ^a   Erdoǧan, Şeyda ^b   Tanyeli, Atila ^a  

^a Department of Medical Biology and Genetics ^*  (Turkey)

^b CUKUROVA UNIVERSITY   (Turkey)

Author keywords

AURKA; Chromosomal aberrations; MYCN; Neuroblastoma

Indexed keywords

EID: 84874027877     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.11.5391     Document Type: Article

References (39)

1. Ambros IM, Zellner A, Roald B, et al (1996). Role of ploidy, chromosome 1p, and Schwann cells in the maturation of neuroblastoma. The New England J Med, 334, 1505-11.
2. Berwanger B, Hartmann O, Bergmann E, et al (2002). Loss of a Fyn-regulated differentiation and growth arrest pathway in advanced stage neuroblastoma. Cancer Cell, 2, 377-86.
3. Brodeur GM, Sekhon GS, Goldstein MN, (1977). Chromosomal aberrations in human neuroblastomas. Cancer, 40, 2256-63.
4. Brodeur GM, Green AA, Hayes FA, et al (1981). Cytogenetic features of human neuroblastomas and cell lines. Cancer Res, 41, 4678-86.
5. Brodeur G (2003). Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer, 3, 203-16.
6. Capasso M, Diskin SJ, (2010). Genetics and genomics of neuroblastoma. Cancer Treat Res, 155, 65-84.
7. Caron H, van Sluis P, Buschman R, et al (1996). Allelic loss of the short arm of chromosome 4 in neuroblastoma suggests a novel tumour suppressor gene locus. Hum Genet, 97, 834-37.
8. Carvajal RD, Tse A, Schwartz GK, (2006). Aurora kinases: new targets for cancer therapy. Clin Cancer Res, 12, 6869-75.
9. Dumanski JP (1996). The human chromosome 22-located genes and malignancies of the central nervous system. Neuropathol Appl Neurobiol, 22, 412-7.
10. Ejeskar K, Aburatani H, Abrahamsson J, et al (1998). Loss of heterozygosity of 3p markers in neuroblastoma tumours implicate a tumoursuppressor locus distal to the FHIT gene. Br J Cancer, 77, 1787-91.
11. Fearon ER, Cho KR, Nigro JM, et al (1990). Identification of a chromosome 18q gene that is altered in colorectal cancers. Sci, 247, 49-56.
12. Fong CT, White PS, Peterson K, et al (1992). Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas. Cancer Res, 52, 1780-5.
13. Fundia AF, Larripa IB, (1989). Coincidence in Fragile Site Expression with Fluorodeoxyuridine and Bromodeoxyuridine. Cancer Genet Cytogenet, 41, 41-8.
14. Gilbert F, Balaban G, Moorhead P, et al (1982). Abnormalities of chromosome 1p in neuroblastoma tumours and cell lines. Cancer Genet Cytogenet, 7, 33-42.
15. Guled M, Myllykangas S, Frierson HF Jr, et al (2008). Array comparative genomic hybridization analysis of olfactory neuroblastoma. Mod Pathol, 21, 770-8.
16. Guo C, White PS, Weiss MJ, et al (1999). Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas. Oncogene, 18, 4948-57.
17. Hahn SA, Schutte M, Hoque AT, et al (1996). DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science (Wash. DC), 271, 350-3.
18. Karaüzüm SB, Lüleci G, özbilim G, et al (1998). Cytogenetic findings in thirty lung carcinoma patients. Cancer Genet Cytogenet, 100, 114-23.
19. Kohl NE, Kanda N, Schreck RR, et al (1983). Transposition and amplification of oncogene-related sequences in human neuroblastomas. Cell, 35, 359-67.
20. Krona C, Caren H, Sjöberg RM, et al (2008). Analysis of neuroblastoma tumour progression; loss of PHOX2B on 4p13 and 17q gain are early events in neuroblastoma tumourigenesis. Int J of Oncol, 32, 575-83.
21. Maris JM, Matthay KK, (1999). Molecular biology of neuroblastoma. J Clin Oncol, 17, 2264-79.
22. Marshall B, Isidro G, Martins AG, Boavida MG (1997). Loss of heterozygosity at chromosome 9p21 in primary neuroblastomas: evidence for two deleted regions. Cancer Genet Cytogenet, 96, 134-9.
23. McAlpine PJ, Shows TB, Boucheli C, Huebner M, Anderson WA (1991). The 1991 catalog of mapped genes and report of the nomenclature committee, human gene mapping 11. Cytogenet Cell Genet, 58, 5-102.
24. Mitelman F (ed.), Skarger, (1995). ISCN: An international system for humn cytogenetics nomenclature. Basel.
25. Mora J, Cheung NK, Chen L, et al (2001). Loss of heterozygosity at 19q13.3 is associated with locally aggressive neuroblastoma. Clin Cancer Res, 7, 1358-61.
26. Nanashima A, Tagawa Y, Yasutake T, et al (1997). Aneusomy of chromosome 18 is associated with the development of colorectal carcinoma. J Gastroenterology, 32, 487-91.
27. Otto T, Horn S, Brockmann M, et al (2009). Stabilization of N-Myc is a critical function of aurora a in human neuroblastoma. Cancer Cell, 15, 67-78.
28. Pandis N, Jin Y, Gorunova L, et al (1995). Chromosome analysis of 97 primary carcinomas of the breast: Identification of eight karyotypic subgroups. Genes Chrom Cancer, 12, 173-85.
29. Petkovic I, Cepulic M (1991). Cytogenetic analysis of primary neuroblastoma with del(1), del(14), hsr, and dmin chromosomes. Cancer Genet Cytogenet, 55, 231-4.
30. Rubie H, Hartmann O, Michon J, et al (1997). N-myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL90 study. J Clin Oncol, 15, 1171-82.
31. Spitz R, Hero B, Ernestus K, Berthold F, (2003). Deletions in chromosome arms 3p and 11q are new prognostic markers in localized and 4 s neuroblastoma. Clin Cancer Res, 9, 52-8.
32. Spitz R, Hero B, Skowron M, Ernestus K, Berthold F, (2004). MYCN status in neuroblastoma: characteristics of tumours showing amplification, gain, and non-amplification. Eur J Cancer, 40, 2753-9.
33. Sreekantaiah C, Bhargava MK, Shetty NJ, (1988). Chromosome 1 abnormalities in cervical carcinoma. Cancer, 62, 1317-24.
34. Sumegi J, Nishio J, Nelson M, et al (2011). A novel t(4;22) (q31;q12) produces an EWSR1-SMARCA5 fusion in extraskeletal Ewing sarcoma/primitive neuroectodermal tumor. Mod Pathol, 24, 333-42.
35. Suzuki T, Yokota J, Mugishima H, et al (1989). Frequent loss of heterozygosity on chromosome 14q in neuroblastoma. Cancer Res, 49, 1095-8.
36. Thompson PM, Seifried BA, Kyemba SK, et al (2001). Loss of heterozygosity for chromosome 14q in neuroblastoma. Med Pediatr Oncol, 36, 28-31.
37. Weiss MJ, Guo C, Shusterman S, et al (2000). Localization of a hereditary neuroblastoma predisposition gene to 16p12- p13. Med Pediatr Oncol, 35, 526-30.
38. Young RP, Whittington CF, Hopkins RJ, et al (2010). Chromosome 4q31 locus in COPD is also associated with lung cancer. Eur Respir J, 36, 1375-82.
39. Zhou H, Kuang J, Zhong L, et al (1998). Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet, 20, 89-193.